We recently sat down with Denis Bedoret, Chief BD Officier at MaSTherCell in Amsterdam at the Cell Therapy Manufacturing & Gene Therapy Congress conference to discuss the critical issues and opportunities present in the cell & gene therapy industry today.
In this exclusive interview, Denis explores the future of the industry, exciting breakthroughs, what is next for MaSTherCell and their main focus for 2017.
Interested in learning more on these topics? Then be sure to register for our upcoming Cell Therapy Manufacturing & Gene Therapy Congress digital week. It is week a free webinars that connects cell and gene therapy leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development, and regulatory know-how. Click here to learn more.